감마 나이프 시장 : 예측(2026-2031년)

The gamma knife market, with a 5.15% CAGR, is anticipated to rise from USD 422.965 million in 2025 to USD 571.712 million in 2031.

Gamma Knife Market: Industry Analysis

The Gamma Knife market is experiencing robust growth at a 5.15% CAGR, projected to reach USD 571.712 million in 2031. This specialized medical device, designed for non-invasive radiosurgery targeting brain tumors and neurological conditions, is gaining prominence as healthcare systems worldwide seek precise, minimally invasive treatment alternatives for complex neurological pathologies.

Fundamental Market Drivers

Brain Tumor Prevalence

The increasing incidence of brain tumors represents a primary catalyst for Gamma Knife market expansion. The device's highly accurate guidance system and specialized collimators enable precise focusing of multiple radiation beams on target lesions, delivering effective treatment while minimizing radiation exposure to healthy brain tissue. This precision is particularly critical given that brain tumors significantly impact life expectancy, reducing it by an average of 27 years-the highest reduction among all cancer types. The technology's ability to target tumors with submillimeter accuracy makes it an increasingly preferred option for neurosurgeons and radiation oncologists managing these challenging cases.

Neurological Disorder Applications

Beyond brain tumors, Gamma Knife radiosurgery has demonstrated effectiveness across various neurological conditions, broadening its clinical utility. The technology treats selected arteriovenous malformations by focusing radiation on aberrant vessels, causing progressive closure over time. Additionally, research has explored Gamma Knife applications for movement disorders including essential tremors and Parkinson's disease. With approximately 42 million people in the U.S. population affected by movement disorders, this expanded therapeutic scope significantly amplifies market potential and positions Gamma Knife technology as a versatile tool in the neurological treatment armamentarium.

Imaging Software Integration

Advancements in imaging software have become instrumental in enhancing Gamma Knife treatment planning and execution. Modern imaging platforms enable precise delineation of target lesions, ensuring accurate targeting during procedures. Three-dimensional imaging capabilities, combined with specialized algorithms and sophisticated tools, facilitate creation of optimized treatment plans that maximize radiation delivery to pathological tissue while minimizing exposure to surrounding healthy structures. These technological refinements continue improving treatment outcomes and expanding the clinical scenarios where Gamma Knife radiosurgery represents a viable option.

Demographic Imperatives

The growing geriatric population constitutes a significant driver, as aging populations experience higher prevalence of brain tumors and neurological conditions. The global demographic shift is substantial: the proportion of people aged over 60 years worldwide is projected to increase from 12% to 22% between 2015 and 2050. Furthermore, the absolute number of individuals aged 60 years or above is estimated to grow from 1 billion in 2020 to 1.4 billion by 2031. This demographic evolution creates sustained demand for effective, minimally invasive treatment solutions that Gamma Knife technology provides.

Educational Initiatives

Increasing awareness among patients and healthcare professionals regarding Gamma Knife radiosurgery benefits is accelerating adoption rates. Educational initiatives, online resources, and information-sharing platforms have enhanced understanding of the technology's capabilities and clinical applications. Specialized training programs have emerged to support workforce development and ensure proper utilization of Gamma Knife systems, facilitating broader implementation across healthcare institutions.

Market Constraints

Despite positive growth trajectories, the Gamma Knife market faces notable challenges. The complexity and specialization of Gamma Knife systems translate to substantial costs that may impede adoption. Healthcare institutions must navigate significant initial equipment investments alongside ongoing maintenance and operational expenses, which can present barriers to integration, particularly for facilities with constrained capital budgets. Additionally, successful implementation requires specialized equipment and qualified medical personnel, potentially limiting availability in certain geographic areas or healthcare settings, especially in developing regions with limited resources or trained specialists.

Regional Dynamics

North America is positioned to maintain a significant market share during the forecast period. This regional strength stems from multiple factors: rising brain tumor incidence, robust healthcare infrastructure, active research initiatives, comprehensive awareness programs, and an expanding elderly population. Projections indicate approximately 25,000 new cases of malignant brain or spinal cord tumors in 2023. The region's population aged 60 years or above is projected to reach 80.8 million by 2040, up from 54.1 million in 2019, with this demographic showing elevated brain cancer risk, further supporting regional market growth.

The Gamma Knife market continues evolving, propelled by technological advancement, demographic shifts, and expanding clinical applications. These converging factors position the market for sustained growth as healthcare systems prioritize precise, non-invasive treatment modalities for complex neurological conditions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Gamma Knife Market Segmentation

• By Disease
• Brain Metastasis
• Cancer
• Arteriovenous Malformation
• Trigeminal Neuralgia
• Others
• By Anatomy
• Head
• Neck
• Others
• By Distribution Channel
• Online
• Offline
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GAMMA KNIFE MARKET BY DISEASE

• 5.1. Introduction
• 5.2. Brain Metastasis
• 5.3. Cancer
• 5.4. Arteriovenous Malformation
• 5.5. Trigeminal Neuralgia
• 5.6. Others

6. GAMMA KNIFE MARKET BY ANATOMY

• 6.1. Introduction
• 6.2. Head
• 6.3. Neck
• 6.4. Others

7. GAMMA KNIFE MARKET BY DISTRIBUTION CHANNEL

• 7.1. Introduction
• 7.2. Online
• 7.3. Offline

8. GAMMA KNIFE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Elekta
• 10.2. Bionity
• 10.3. Mayo Clinic
• 10.4. Beaumont Health
• 10.5. Intermountain Healthcare
• 10.6. Karolinska
• 10.7. Allina Health
• 10.8. Riverside Health Systems
• 10.9. Varian Medical Systems
• 10.10. Akesis Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations